BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Insulin aspart (Fiasp) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Insulin aspart (Fiasp)\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07652528-11042@assetmemo.bio
DTSTAMP:20261121T010010Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Insulin aspart (Fiasp): Phase na readout est. (NCT07652528)
DESCRIPTION:Insulin aspart (Fiasp)\, phase na\, Type 2 Diabetes.\nStudy: CG
 M-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglyc
 emia in Sudden Sensorineural Hearing Loss: SHIP Trial\nEstimated primary c
 ompletion: June 2028. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /insulin-aspart-fiasp#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07652528
URL:https://assetmemo.bio/drug/insulin-aspart-fiasp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
